Phase out D4T in poor countries

Home / Health / Phase out D4T in poor countries

Stavudine (D4T) was previously one of three antiretroviral drugs (ARVs) recommended as first-line treatment but serious side effects, seen in many studies and treatment programmes, led to calls to use better, less toxic drugs.Click here to read more on Quackdown.

Author

  • Health-e News

    Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews

    View all posts

Support Our Work. Make A Donation

Donate Here!

Free to Share

Creative Commons License

Republish our articles for free, online or in print, under a Creative Commons license.


MOST READ

EDITOR'S PICKS

Newsletter Subscription

Be in the know with our free weekly newsletter. We deliver a round-up of our top stories and insightful reads from across the web.

  • This field is for validation purposes and should be left unchanged.
Enable Notifications OK No thanks